These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 6771000

  • 1. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K, Ito S, Inoue S, Yamamoto Y, Takeuchi J, Shamoto M, Nagatsu T.
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
    Ito S, Inoue S, Yamamoto Y, Fujita K.
    J Med Chem; 1981 Jun; 24(6):673-7. PubMed ID: 6788955
    [Abstract] [Full Text] [Related]

  • 3. The mechanism of toxicity of 5-S-cysteinyldopa to tumour cells. Hydrogen peroxide as a mediator of cytotoxicity.
    Ito S, Inoue S, Fujita K.
    Biochem Pharmacol; 1983 Jul 01; 32(13):2079-81. PubMed ID: 6409113
    [Abstract] [Full Text] [Related]

  • 4. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S, Jimbow K, Kato T, Kiyota M, Fujita K.
    Acta Derm Venereol; 1983 Jul 01; 63(6):463-7. PubMed ID: 6198833
    [Abstract] [Full Text] [Related]

  • 5. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL, Wu MS, Chen Z.
    Acta Pharmacol Sin; 2002 Oct 01; 23(10):946-51. PubMed ID: 12370101
    [Abstract] [Full Text] [Related]

  • 6. Levodopa and dopamine analogs: melanin precursors as antitumor agents in experimental human and murine leukemia.
    Wick MM.
    Cancer Treat Rep; 1979 Jun 01; 63(6):991-7. PubMed ID: 466656
    [Abstract] [Full Text] [Related]

  • 7. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.
    Haase C, Bergmann R, Fuechtner F, Hoepping A, Pietzsch J.
    J Nucl Med; 2007 Dec 01; 48(12):2063-71. PubMed ID: 18056335
    [Abstract] [Full Text] [Related]

  • 8. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U, Mett H, Stanek J, Mueller M, Kramer D, Porter CW.
    Cancer Res; 1994 Jun 15; 54(12):3210-7. PubMed ID: 8205541
    [Abstract] [Full Text] [Related]

  • 9. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1995 May 15; 429():1-286. PubMed ID: 12616302
    [Abstract] [Full Text] [Related]

  • 10. DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells.
    Parsons PG, Morrison LE.
    Cancer Res; 1982 Sep 15; 42(9):3783-8. PubMed ID: 6809313
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL, Hurd SD, Dugger TC, Winnier AR, Robertson JB.
    Cancer Res; 1994 Sep 01; 54(17):4703-9. PubMed ID: 8062268
    [Abstract] [Full Text] [Related]

  • 12. Melanogenesis in cultured human neuroblastomas.
    Aubert C, Janiaud P, Rouge F, Hansson C, Rorsman H, Rosengren E.
    Ann Clin Res; 1980 Dec 01; 12(6):288-94. PubMed ID: 6786205
    [Abstract] [Full Text] [Related]

  • 13. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 01; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 14. Augmentation by L-dopa of growth inhibition and melanin formation of X-irradiated Harding-Passey melanoma cells in culture.
    Schachtschabel DO, Pfab R, Paul N, Hess F.
    Strahlenther Onkol; 1988 Jul 01; 164(7):419-24. PubMed ID: 3400051
    [Abstract] [Full Text] [Related]

  • 15. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
    Agrup G, Falck B, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1977 Jul 01; 57(4):313-5. PubMed ID: 70922
    [Abstract] [Full Text] [Related]

  • 16. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR, Chen SF, Behrens CH, Papp LM, Stafford MM, Sun JH, Behrens DL, Fredericks JR, Polkus ST, Sipple P.
    Cancer Res; 1994 Apr 15; 54(8):2199-206. PubMed ID: 8174127
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor effect of N-beta-alanyl-5-S-glutathionyldihydroxyphenylalanine (5-S-GAD), a novel anti-bacterial substance from an insect.
    Akiyama N, Hijikata M, Kobayashi A, Yamori T, Tsuruo T, Natori S.
    Anticancer Res; 2000 Apr 15; 20(1A):357-62. PubMed ID: 10769680
    [Abstract] [Full Text] [Related]

  • 18. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM, Erickson LC, Ringsdorf H, Zaharko DS.
    Cancer Res; 1980 Oct 15; 40(10):3704-8. PubMed ID: 7438053
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of pheomelanogenesis by L-dopa in the mouse melanocyte cell line, TM10, in vitro.
    Sato C, Ito S, Takeuchi T.
    J Cell Sci; 1987 May 15; 87 ( Pt 4)():507-12. PubMed ID: 2888776
    [Abstract] [Full Text] [Related]

  • 20. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1980 May 15; 60(5):399-402. PubMed ID: 6162310
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.